Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gastrin
, a gastrointestinal hormone responsible for gastric acid secretion, has been confirmed as a growth factor for gastrointestinal tract malignancies. High expression of
gastrin
mRNA was observed in pancreatic and colorectal cancer; however, the mechanism is unclear. Epidermal growth factor (EGF) was found to increase
gastrin
mRNA stability, indicating mRNA turnover regulation mechanism is involved in the control of
gastrin
mRNA expression. Using biotin-labeled RNA probe pull-down assay combined with mass spectrometry analysis, we identified the heterogeneous nuclear ribonucleoprotein K (
hnRNP K
) and poly(C) binding protein 1 (PCBP1) bound with the C-rich region in
gastrin
mRNA 3' untranslated region. Nucleolin bound with the AGCCCU motif and interacted with
hnRNP K
were also demonstrated. Under EGF treatment, we observed the amount of nucleolin interacting with
hnRNP K
and
gastrin
mRNA increased. Using small interfering RNA technology to define their functional roles, we found
hnRNP K
, PCBP1, and nucleolin were all responsible for stabilizing
gastrin
mRNA. Moreover, nucleolin plays a crucial role in mediating the increased
gastrin
mRNA stability induced by EGF signaling. Besides, we also observed
hnRNP K
/PCBP1 complex bound with the C-rich region in the
gastrin
mRNA increased nucleolin binding with
gastrin
mRNA. Finally, a novel binding model was proposed.
...
PMID:Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C) binding protein 1 complex to regulate the gastrin mRNA turnover. 1792 3